Your browser doesn't support javascript.
loading
Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids.
Semova, Ivana; Levenson, Amy E; Krawczyk, Joanna; Bullock, Kevin; Gearing, Mary E; Ling, Alisha V; Williams, Kathryn A; Miao, Ji; Adamson, Stuart S; Shin, Dong-Ju; Chahar, Satyapal; Graham, Mark J; Crooke, Rosanne M; Hagey, Lee R; Vicent, David; de Ferranti, Sarah D; Kidambi, Srividya; Clish, Clary B; Biddinger, Sudha B.
Afiliación
  • Semova I; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Levenson AE; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Krawczyk J; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Bullock K; Broad Institute of MIT and Harvard, Cambridge, MA (K.B., C.B.C.).
  • Gearing ME; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Ling AV; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Williams KA; Biostatistics and Research Design Center, ICCTR, Boston Children's Hospital, MA (K.A.W.).
  • Miao J; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Adamson SS; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Shin DJ; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Chahar S; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
  • Graham MJ; Ionis Pharmaceuticals, Carlsbad, CA (M.J.G., R.M.C.).
  • Crooke RM; Ionis Pharmaceuticals, Carlsbad, CA (M.J.G., R.M.C.).
  • Hagey LR; Department of Medicine, University of California, San Diego (L.R.H.).
  • Vicent D; Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain (D.V.).
  • de Ferranti SD; Department of Cardiology (S.D.d.F.), Boston Children's Hospital, Harvard Medical School, MA.
  • Kidambi S; Department of Medicine, Medical College of Wisconsin, Milwaukee (S.K.).
  • Clish CB; Broad Institute of MIT and Harvard, Cambridge, MA (K.B., C.B.C.).
  • Biddinger SB; Division of Endocrinology (I.S., A.E.L., J.K., M.E.G., A.V.L., J.M., S.S.A., D.-J.S., S.C., S.B.B.), Boston Children's Hospital, Harvard Medical School, MA.
Circulation ; 145(13): 969-982, 2022 03 29.
Article en En | MEDLINE | ID: mdl-35193378

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipercolesterolemia / Hiperlipidemias Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Circulation Año: 2022 Tipo del documento: Article País de afiliación: Marruecos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipercolesterolemia / Hiperlipidemias Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Circulation Año: 2022 Tipo del documento: Article País de afiliación: Marruecos